Cathepsin cysteine proteases in cardiovascular disease

FASEB Journal

Volumn 21, Issue 12, 2007, Pages 3029-3041

  Lutgens, Suzanne P M ^a   Cleutjens, Kitty B J M ^a   Daemen, Mat J A P ^a   Heeneman, Sylvia ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atherosclerosis; Diagnostic tool; Extracellular matrix; Lipid metabolism; Therapeutic potential

Indexed keywords

BALICATIB; CATHEPSIN; CATHEPSIN K; CATHEPSIN K INHIBITOR; CATHEPSIN L; CATHEPSIN S; CATHEPSIN S INHIBITOR; CHOLESTEROL; COLLAGENASE 3; CYSTATIN C; CYSTEINE PROTEINASE; GAMMA INTERFERON; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; LIPID; LOW DENSITY LIPOPROTEIN; MACROPHAGE ELASTASE; MATRILYSIN; RELACATIB; TRANSFORMING GROWTH FACTOR BETA1; CYSTATIN; ISOENZYME; MATRIX METALLOPROTEINASE;

ANEURYSM; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DIAGNOSTIC VALUE; ENZYME ANALYSIS; EXTRACELLULAR MATRIX; FOAM CELL; HUMAN; IN VIVO STUDY; KNOCKOUT GENE; LIPID METABOLISM; NEOVASCULARIZATION (PATHOLOGY); OSTEOARTHRITIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SHEAR STRESS; ANGIOGENESIS; ANIMAL; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; INFLAMMATION; METABOLISM; PATHOLOGY; RESTENOSIS; SHEAR STRENGTH;

ANEURYSM; ANIMALS; CARDIOVASCULAR DISEASES; CATHEPSINS; CORONARY RESTENOSIS; CYSTATINS; EXTRACELLULAR MATRIX; HUMANS; INFLAMMATION; ISOENZYMES; LIPID METABOLISM; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PHYSIOLOGIC; SHEAR STRENGTH;

EID: 35248897299     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-7924com     Document Type: Review

References (100)

1. Newby, A. C. (2005) Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 85, 1-31
2. Keeling, W. B., Armstrong, P. A., Stone, P. A., Bandyk, D. F., and Shames, M. L. (2005) An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc. Endovascular. Surg. 39, 457-464
3. Lijnen, H. R. (2003) Metalloproteinases in development and progression of vascular disease. Pathophysiol. Haemost. Thromb. 33, 275-281
4. Liu, J., Sukhova, G. K., Sun, J. S., Xu, W. H., Libby, P., and Shi, G. P. (2004) Lysosomal cysteine proteases in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24, 1359-1366
5. Sukhova, G. K., and Shi, G. P. (2006) Do cathepsins play a role in abdominal aortic aneurysm pathogenesis. Ann. N. Y. Acad. Sci. 1085, 161-169
6. Neurath, H., and Walsh, K. A. (1976) Role of proteolytic enzymes in biological regulation (a review). Proc. Natl. Acad. Sci. U. S. A. 73, 3825-3832
7. Chapman, H. A., Riese, R. J., and Shi, G. P. (1997) Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59, 63-88
8. Turk, B., Turk, V., and Turk, D. (1997) Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol. Chem. 378, 141-150
9. Turk, B., Turk, D., and Turk, V. (2000) Lysosomal cysteine proteases: more than scavengers. Biochim. Biophys. Acta 1477, 98-111
10. Turk, V., Turk, B., and Turk, D. (2001) Lysosomal cysteine proteases: facts and opportunities. EMBO J. 20, 4629-4633
11. Aronson, N. N., Jr., and Barrett, A. J. (1978) The specificity of cathepsin B. Hydrolysis of glucagon at the C-terminus by a peptidyldipeptidase mechanism. Biochem. J. 171, 759-765
12. Koga, H., Mori, N., Yamada, H., Nishimura, Y., Tokuda, K., Kato, K., and Imoto, T. (1992) Endo- and aminopeptidase activities of rat cathepsin H. Chem. Pharm. Bull. (Tokyo) 40, 965-970
13. Klemencic, I., Carmona, A. K., Cezari, M. H., Juliano, M. A., Juliano, L., Guncar, G., Turk, D., Krizaj, I., Turk, V., and Turk, B. (2000) Biochemical characterization of human cathepsin X revealed that the enzyme is an exopeptidase, acting as carboxymonopeptidase or carboxydipeptidase. Eur. J. Biochem. 267, 5404-5412
14. Dubin, G. (2005) Proteinaceous cysteine protease inhibitors. Cell Mol. Life. Sci. 62, 653-669
15. Turk, V., and Bode, W. (1991) The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 285, 213-219
16. Hall, A., Ekiel, I., Mason, R. W., Kasprzykowski, F., Grubb, A., and Abrahamson, M. (1998) Structural basis for different inhibitory specificities of human cystatins C and D. Biochemistry 37, 4071-4079
17. Hart, T. C., Hart, P. S., Bowden, D. W., Michalec, M. D., Callison, S. A., Walker, S. J., Zhang, Y., and Firatli, E. (1999) Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome. J. Med. Genet. 36, 881-887
18. Gelb, B. D., Shi, G. P., Chapman, H. A., and Desnick, R. J. (1996) Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273, 1236-1238
19. Deussing, J., Roth, W., Saftig, P., Peters, C., Ploegh, H. L., and Villadangos, J. A. (1998) Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc. Natl. Acad. Sci. U. S. A. 95, 4516-4521
20. Tang, C. H., Lee, J. W., Galvez, M. G., Robillard, L., Mole, S. E., and Chapman, H. A. (2006) Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease. Mol. Cell Biol. 26, 2309-2316
21. Saftig, P., Hunziker, E., Wehmeyer, O., Jones, S., Boyde, A., Rommerskirch, W., Moritz, J. D., Schu, P., and von Figura, K. (1998) Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 95, 13453-13458
22. Nakagawa, T. Y., Brissette, W. H., Lira, P. D., Griffiths, R. J., Petrushova, N., Stock, J., McNeish, J. D., Eastman, S. E., Howard, E. D., Clarke, S. R., et al. (1999) Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 10, 207-217
23. Shi, G. P., Villadangos, J. A., Dranoff, G., Small, C., Gu, L., Haley, K. J., Riese, R., Ploegh, H. L., and Chapman, H. A. (1999) Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 10, 197-206
24. Ondr, J. K., and Pham, C. T. (2004) Characterization of murine cathepsin W and its role in cell-mediated cytotoxicity. J. Biol. Chem. 279, 27525-27533
25. Maciewicz, R. A., Wotton, S. F., Etherington, D. J., and Duance, V. C. (1990) Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L. FEBS Lett. 269, 189-193
26. Bromme, D., Okamoto, K., Wang, B. B., and Biroc, S. (1996) Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J. Biol. Chem. 271, 2126-2132
27. Garnero, P., Borel, O., Byrjalsen, I., Ferreras, M., Drake, F. H., McQueney, M. S., Foged, N. T., Delmas, P. D., and Delaisse, J. M. (1998) The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J. Biol. Chem. 273, 32347-32352
28. Yasuda, Y., Li, Z., Greenbaum, D., Bogyo, M., Weber, E., and Bromme, D. (2004) Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages. J. Biol. Chem. 279, 36761-36770
29. Shi, G. P., Munger, J. S., Meara, J. P., Rich, D. H., and Chapman, H. A. (1992) Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J. Biol. Chem. 267, 7258-7262
30. Honey, K., and Rudensky, A. Y. (2003) Lysosomal cysteine proteases regulate antigen presentation. Nat. Rev. Immunol. 3, 472-482
31. Hsing, L. C., and Rudensky, A. Y. (2005) The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol. Rev. 207, 229-241
32. Shi, G. P., Bryant, R. A., Riese, R., Verhelst, S., Driessen, C., Li, Z., Bromme, D., Ploegh, H. L., and Chapman, H. A. (2000) Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191, 1177-1186
33. Hsieh, C. S., deRoos, P., Honey, K., Beers, C., and Rudensky, A. Y. (2002) A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation. J. Immunol. 168, 2618-2625
34. Riese, R. J., Mitchell, R. N., Villadangos, J. A., Shi, G. P., Palmer, J. T., Karp, E. R., De Sanctis, G. T., Ploegh, H. L., and Chapman, H. A. (1998) Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 101, 2351-2363
35. Beers, C., Honey, K., Fink, S., Forbush, K., and Rudensky, A. (2003) Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages. J. Exp. Med. 197, 169-179
36. Bania, J., Gatti, E., Lelouard, H., David, A., Cappello, F., Weber, E., Camosseto, V., and Pierre, P. (2003) Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs. Proc. Natl. Acad. Sci. U. S. A. 100, 6664-6669
37. Beers, C., Burich, A., Kleijmeer, M. J., Griffith, J. M., Wong, P., and Rudensky, A. Y. (2005) Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo. J. Immunol. 174, 1205-1212
38. Chwieralski, C. E., Welte, T., and Buhling, F. (2006) Cathepsin-regulated apoptosis. Apoptosis 11, 143-149
39. Li, W., and Yuan, X. M. (2004) Increased expression and translocation of lysosomal cathepsins contribute to macrophage apoptosis in atherogenesis. Ann. N. Y. Acad. Sci. 1030, 427-433
40. Li, W., Dalen, H., Eaton, J. W., and Yuan, X. M. (2001) Apoptotic death of inflammatory cells in human atheroma. Arterioscler. Thromb. Vasc. Biol. 21, 1124-1130
41. Liu, N., Raja, S. M., Zazzeroni, F., Metkar, S. S., Shah, R., Zhang, M., Wang, Y., Bromme, D., Russin, W. A., Lee, J. C., et al. (2003) NF-kappaB protects from the lysosomal pathway of cell death. EMBO J. 22, 5313-5322
42. Reddy, V. Y., Zhang, Q. Y., and Weiss, S. J. (1995) Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc. Natl. Acad. Sci. U. S. A. 92, 3849-3853
43. Jormsjo, S., Wuttge, D. M., Sirsjo, A., Whatling, C., Hamsten, A., Stemme, S., and Eriksson, P. (2002) Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 161, 939-945
44. Sukhova, G. K., Shi, G. P., Simon, D. I., Chapman, H. A., and Libby, P. (1998) Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J. Clin. Invest. 102, 576-583
45. Chen, J., Tung, C. H., Mahmood, U., Ntziachristos, V., Gyurko, R., Fishman, M. C., Huang, P. L., and Weissleder, R. (2002) In vivo imaging of proteolytic activity in atherosclerosis. Circulation 105, 2766-2771
46. Oorni, K., Sneck, M., Bromme, D., Pentikainen, M. O., Lindstedt, K. A., Mayranpaa, M., Aitio, H., and Kovanen, P. T. (2004) Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro. J. Biol. Chem. 279, 34776-34784
47. Liu, J., Sukhova, G. K., Yang, J. T., Sun, J., Ma, L., Ren, A., Xu, W. H., Fu, H., Dolganov, G. M., Hu, C., Libby, P., and Shi, G. P. (2006) Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis 184, 302-311
48. Lutgens, E., Lutgens, S. P., Faber, B. C., Heeneman, S., Gijbels, M. M., de Winther, M. P., Frederik, P., van der Made, I., Daugherty, A., Sijbers, A. M., et al. (2006) Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation 113, 98-107
49. Sukhova, G. K., Zhang, Y., Pan, J. H., Wada, Y., Yamamoto, T., Naito, M., Kodama, T., Tsimikas, S., Witztum, J. L., Lu, M. L., et al. (2003) Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 111, 897-906
50. Rodgers, K. J., Watkins, D. J., Miller, A. L., Chan, P. Y., Karanam, S., Brissette, W. H., Long, C. J., and Jackson, C. L. (2006) Destabilizing role of cathepsin S in murine atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 26, 851-856
51. Lutgens, S., Kisters, N., Lutgens, E., van Haaften, R., Evelo, C., de Winther, M., Saftig, P., Daemen, M., Heeneman, S., and Cleutjens, K. (2006) Gene profiling of cathepsin K deficiency in atherogenesis: profibrotic but lipogenic. J. Pathol. 210, 334-343
52. Cheng, X. W., Kuzuya, M., Nakamura, K., Di, Q., Liu, Z., Sasaki, T., Kanda, S., Jin, H., Shi, G. P., Murohara, T., Yokota, M., and Iguchi, A. (2006) Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3. Am. J. Pathol. 168, 685-694
53. Punturieri, A., Filippov, S., Allen, E., Caras, I., Murray, R., Reddy, V., and Weiss, S. J. (2000) Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J. Exp. Med. 192, 789-799
54. Zarins, C. K., Giddens, D. P., Bharadvaj, B. K., Sottiurai, V. S., Mabon, R. F., and Glagov, S. (1983) Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ. Res. 53, 502-514
55. Platt, M. O., Ankeny, R. F., and Jo, H. (2006) Laminar shear stress inhibits cathepsin L activity in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26, 1784-1790
56. Platt, M. O., Ankeny, R. F., Shi, G. P., Weiss, D., Taylor, W. R., Vega, J. D., and Jo, H. (2006) Expression of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased in endothelium in human atherosclerosis. Am. J. Physiol. 292, H1479-H1486
57. Li, W., Yuan, X. M., Olsson, A. G., and Brunk, U. T. (1998) Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation. Arterioscler. Thromb. Vasc. Biol. 18, 177-184
58. Tertov, V. V., and Orekhov, A. N. (1997) Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima. Exp. Mol. Pathol. 64, 127-145
59. Lindstedt, L., Lee, M., Oorni, K., Bromme, D., and Kovanen, P. T. (2003) Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells. Biochem. Biophys. Res. Commun. 312, 1019-1024
60. Lutgens, E., Gijbels, M., Smook, M., Heeringa, P., Gotwals, P., Koteliansky, V. E., and Daemen, M. J. (2002) Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler. Thromb. Vasc. Biol. 22, 975-982
61. Shi, G. P., Sukhova, G. K., Grubb, A., Ducharme, A., Rhode, L. H., Lee, R. T., Ridker, P. M., Libby, P., and Chapman, H. A. (1999) Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J. Clin. Invest. 104, 1191-1197
62. Bengtsson, E., To, F., Hakansson, K., Grubb, A., Branen, L., Nilsson, J., and Jovinge, S. (2005) Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 25, 2151-2156
63. Sukhova, G. K., Wang, B., Libby, P., Pan, J. H., Zhang, Y., Grubb, A., Fang, K., Chapman, H. A., and Shi, G. P. (2005) Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ. Res. 96, 368-375
64. Schwartz, R. S., and Henry, T. D. (2002) Pathophysiology of coronary artery restenosis. Rev. Cardiovasc. Med. 3. Suppl. 5, S4-S9
65. Burns-Kurtis, C. L., Olzinski, A. R., Needle, S., Fox, J. H., Capper, E. A., Kelly, F. M., McQueney, M. S., and Romanic, A. M. (2004) Cathepsin S expression is up-regulated following balloon angioplasty in the hypercholesterolemic rabbit. Cardiovasc. Res. 62, 610-620
66. Cheng, X. W., Kuzuya, M., Sasaki, T., Arakawa, K., Kanda, S., Sumi, D., Koike, T., Maeda, K., Tamaya-Mori, N., Shi, G. P., et al. (2004) Increased expression of elastolytic cysteine proteases, cathepsins S and K, in the neointima of balloon-injured rat carotid arteries. Am. J. Pathol. 164, 243-251
67. Kadoglou, N. P., and Liapis, C. D. (2004) Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Curr. Med. Res. Opin. 20, 419-432
68. Shimizu, K., Mitchell, R. N., and Libby, P. (2006) Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 26, 987-994
69. Alcorn, H. G., Wolfson, S. K., Jr., Sutton-Tyrrell, K., Kuller, L. H., and OÆLeary, D. (1996) Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol. 16, 963-970
70. Gacko, M., Chyczewski, L., and Chrostek, L. (1999) Distribution, activity and concentration of cathepsin B and cystatin C in the wall of aortic aneurysm. Pol. J. Pathol. 50, 83-86
71. Gacko, M., and Glowinski, S. (1998) Cathepsin D and cathepsin L activities in aortic aneurysm wall and parietal thrombus. Clin. Chem. Lab. Med. 36, 449-452
72. Gacko, M., and Glowinski, S. (1998) Activities of proteases in parietal thrombus of aortic aneurysm. Clin. Chim. Acta 271, 171-177
73. Premzl, A., Turk, V., and Kos, J. (2006) Intracellular proteolytic activity of cathepsin B is associated with capillary-like tube formation by endothelial cells in vitro. J. Cell Biochem. 97, 1230-1240
74. Wang, B., Sun, J., Kitamoto, S., Yang, M., Grubb, A., Chapman, H. A., Kalluri, R., and Shi, G. P. (2006) Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J. Biol. Chem. 281, 6020-6029
75. Shi, G. P., Sukhova, G. K., Kuzuya, M., Ye, Q., Du, J., Zhang, Y., Pan, J. H., Lu, M. L., Cheng, X. W., Iguchi, A., et al. (2003) Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ. Res. 92, 493-500
76. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., and Isner, J. M. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967
77. Khurana, R., Simons, M., Martin, J. F., and Zachary, I. C. (2005) Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 112, 1813-1824
78. Urbich, C., Heeschen, C., Aicher, A., Sasaki, K., Bruhl, T., Farhadi, M. R., Vajkoczy, P., Hofmann, W. K., Peters, C., Pennacchio, L. A., et al. (2005) Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat. Med. 11, 206-213
79. Hristov, M., Zernecke, A., Bidzhekov, K., Liehn, E. A., Shagdarsuren, E., Ludwig, A., and Weber, C. (2007) Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ. Res. 100, 590-597
80. Herrmann, J., Lerman, L. O., Mukhopadhyay, D., Napoli, C., and Lerman, A. (2006) Angiogenesis in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 26, 1948-1945
81. Moreno, P. R., Purushothaman, K. R., Sirol, M., Levy, A. P., and Fuster, V. (2006) Neovascularization in human atherosclerosis. Circulation 113, 2245-2252
82. Purushothaman, K. R., Sanz, J., Zias, E., Fuster, V., and Moreno, P. R. (2006) Atherosclerosis neovascularization and imaging. Curr. Mol. Med. 6, 549-556
83. Okaji, M., Sakai, H., Sakai, E., Shibata, M., Hashimoto, F., Kobayashi, Y., Yoshida, N., Okamoto, K., Yamamoto, K., and Kato, Y. (2003) The regulation of bone resorption in tooth formation and eruption processes in mouse alveolar crest devoid of cathepsin k. J. Pharmacol. Sci. 91, 285-294
84. Everts, V., Delaisse, J. M., Korper, W., and Beertsen, W. (1998) Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone. J. Bone Miner. Res. 13, 1420-1430
85. Everts, V., Korper, W., Jansen, D. C., Steinfort, J., Lammerse, I., Heera, S., Docherty, A. J., and Beertsen, W. (1999) Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J. 13, 1219-1230
86. Shorey, S., Heersche, J. N., and Manolson, M. F. (2004) The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula. Bone 35, 909-917
87. Everts, V., Korper, W., Hoeben, K. A., Jansen, I. D., Bromme, D., Cleutjens, K. B., Heeneman, S., Peters, C., Reinheckel, T., Saftig, P., and Beertsen, W. (2006) Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J. Bone Miner. Res. 21, 1399-1408
88. Johnson, J. L., George, S. J., Newby, A. C., and Jackson, C. L. (2005) Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc. Natl. Acad. Sci. U. S. A. 102, 15575-15580
89. Johnson, J. L., Baker, A. H., Oka, K., Chan, L., Newby, A. C., Jackson, C. L., and George, S. J. (2006) Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis. Circulation 113, 2435-2444
90. Tung, W. S., Lee, J. K., and Thompson, R. W. (2001) Simultaneous analysis of 1176 gene products in normal human aorta and abdominal aortic aneurysms using a membrane-based complementary DNA expression array. J. Vasc. Surg. 34, 143-150
91. Van Vlijmen-van Keulen, C. J., Vahl, A. C., Hennekam, R. C., Rauwerda, J. A., and Pals, G. (2003) Genetic linkage of candidate genes in families with abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 26, 205-210
92. Gacko, M., Ostapowicz, R., Chrostek, L., Worowska, A., and Kordecki, K. (2005) Activity of enzymes with different subcellular localization in the blood plasma of patients with aortic aneurysm. Med. Sci. Monit. 11, CR 211-213
93. Liu, J., Ma, L., Yang, J., Ren, A., Sun, Z., Yan, G., Sun, J., Fu, H., Xu, W., Hu, C., and Shi, G. P. (2006) Increased serum cathepsin S in patients with atherosclerosis and diabetes. Atherosclerosis 186, 411-419
94. Taleb, S., Lacasa, D., Bastard, J. P., Poitou, C., Cancello, R., Pelloux, V., Viguerie, N., Benis, A., Zucker, J. D., Bouillot, J. L., et al. (2005) Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis. FASEB J. 19, 1540-1542
95. Ix, J. H., Shlipak, M. G., Chertow, G. M., and Whooley, M. A. (2007) Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 115, 173-179
96. Fach, E. M., Garulacan, L. A., Gao, J., Xiao, Q., Storm, S. M., Dubaquie, Y. P., Hefta, S. A., and Opiteck, G. J. (2004) In vitro biomarker discovery for atherosclerosis by proteomics. Mol. Cell Proteomics 3, 1200-1210
97. Abbenante, G., and Fairlie, D. P. (2005) Protease inhibitors in the clinic. Med. Chem. 1, 71-104
98. Yasuda, Y., Kaleta, J., and Bromme, D. (2005) The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics. Adv. Drug. Deliv. Rev. 57, 973-993
99. Kumar, S., Dare, L., Vasko-Moser, J. A., James, I. E., Blake, S. M., Rickard, D. J., Hwang, S. M., Tomaszek, T., Yamashita, D. S., Marquis, R. W., Oh, H., et al. (2007) A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys. Bone 40, 122-131
100. Yamashita, D. S., Marquis, R. W., Xie, R., Nidamarthy, S. D., Oh, H. J., Jeong, J. U., Erhard, K. F., Ward, K. W., Roethke, T. J., Smith, B. R., et al. (2006) Structure activity relationships of 5-, 6-, and 7-methyl-substituted azepan-3-one cathepsin K inhibitors. J. Med. Chem. 49, 1597-1612